BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1569089)

  • 1. Identification of a single base change in ribosomal RNA leading to erythromycin resistance.
    Vannuffel P; Di Giambattista M; Morgan EA; Cocito C
    J Biol Chem; 1992 Apr; 267(12):8377-82. PubMed ID: 1569089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel erythromycin resistance plasmid from Bacillus sp. strain HS24, isolated from the marine sponge Haliclona simulans.
    Barbosa TM; Phelan RW; Leong D; Morrissey JP; Adams C; Dobson AD; O'Gara F
    PLoS One; 2014; 9(12):e115583. PubMed ID: 25548909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of the Genetic Code Through the Use of Modified Bacterial Ribosomes.
    Hecht SM
    J Mol Biol; 2022 Apr; 434(8):167211. PubMed ID: 34419431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial Resistance to Antimicrobial Agents.
    Varela MF; Stephen J; Lekshmi M; Ojha M; Wenzel N; Sanford LM; Hernandez AJ; Parvathi A; Kumar SH
    Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34067579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to Macrolide Antibiotics in Public Health Pathogens.
    Fyfe C; Grossman TH; Kerstein K; Sutcliffe J
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27527699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemobiosynthesis of new antimalarial macrolides.
    Goodman CD; Useglio M; Peirú S; Labadie GR; McFadden GI; Rodríguez E; Gramajo H
    Antimicrob Agents Chemother; 2013 Feb; 57(2):907-13. PubMed ID: 23208707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombineering reveals a diverse collection of ribosomal proteins L4 and L22 that confer resistance to macrolide antibiotics.
    Diner EJ; Hayes CS
    J Mol Biol; 2009 Feb; 386(2):300-15. PubMed ID: 19150357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori.
    Rimbara E; Noguchi N; Kawai T; Sasatsu M
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3465-6. PubMed ID: 18606842
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.
    Matsuoka M; Narita M; Okazaki N; Ohya H; Yamazaki T; Ouchi K; Suzuki I; Andoh T; Kenri T; Sasaki Y; Horino A; Shintani M; Arakawa Y; Sasaki T
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4624-30. PubMed ID: 15561835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin.
    Harms JM; Schlünzen F; Fucini P; Bartels H; Yonath A
    BMC Biol; 2004 Apr; 2():4. PubMed ID: 15059283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide resistance conferred by base substitutions in 23S rRNA.
    Vester B; Douthwaite S
    Antimicrob Agents Chemother; 2001 Jan; 45(1):1-12. PubMed ID: 11120937
    [No Abstract]   [Full Text] [Related]  

  • 13. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics.
    Wang G; Taylor DE
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1952-8. PubMed ID: 9687389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes.
    Occhialini A; Urdaci M; Doucet-Populaire F; Bébéar CM; Lamouliatte H; Mégraud F
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2724-8. PubMed ID: 9420046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.
    Ross JI; Eady EA; Cove JH; Jones CE; Ratyal AH; Miller YW; Vyakrnam S; Cunliffe WJ
    Antimicrob Agents Chemother; 1997 May; 41(5):1162-5. PubMed ID: 9145890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of streptogramins and macrolides.
    Vannuffel P; Cocito C
    Drugs; 1996; 51 Suppl 1():20-30. PubMed ID: 8724813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease.
    Nash KA; Inderlied CB
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2625-30. PubMed ID: 8592991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin.
    Pfefferkorn ER; Borotz SE
    Antimicrob Agents Chemother; 1994 Jan; 38(1):31-7. PubMed ID: 8141576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain.
    Vannuffel P; Di Giambattista M; Cocito C
    Nucleic Acids Res; 1994 Oct; 22(21):4449-53. PubMed ID: 7971275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloroplast ribosomes and protein synthesis.
    Harris EH; Boynton JE; Gillham NW
    Microbiol Rev; 1994 Dec; 58(4):700-54. PubMed ID: 7854253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.